Nifty

:

24853.40

Sensex

:

81583.30

-93.10 (-0.37%)
-212.85 (-0.26%)

Login

Nifty
Sensex

:
:

24853.40
81583.30

-93.10 (-0.37%)
-212.85 (-0.26%)

Solara Active Pharma Sciences Ltd.

Pharmaceuticals & Drugs - API

Rating :

44/99

BSE: 541540 | NSE: SOLARA

Watchlist

NSE BSE

519.10

17-Jun-2025

Open
High
Low
Previous Close

514
541
510
508.65

Volume
Traded Value (lacs)
52 Week High
52 Week Low

592264
311376509.25
882.8
417.15

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

2,501.79
N/A
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

3,273.74
N/A
2.22

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

-
-0.50
0.54

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
-
-

PAT CAGR (%)

10 Years
5 Years
3 Years

-
-
113.69

P:E (Median)

8 Years
5 Years
3 Years

-
-
-

P:BV (Average)

8 Years
5 Years
3 Years

-
2.00
1.51

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-
-1.33
-11.80

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var%
Net Sales 273.01 299.43 -8.82% 300.31 211.94 41.70% 346.95 425.24 -18.41% 363.49 352.31 3.17%
Expenses 230.42 289.63 -20.44% 242.62 373.61 -35.06% 285.63 387.57 -26.30% 321.25 333.17 -3.58%
EBITDA 42.59 9.80 334.59% 57.69 -161.67 - 61.32 37.67 62.78% 42.24 19.14 120.69%
EBIDTM 15.60% 3.27% 19.21% -76.28% 17.67% 8.86% 11.62% 5.43%
Other Income 5.95 1.63 265.03% 1.49 0.44 238.64% 0.32 1.23 -73.98% 1.38 2.07 -33.33%
Interest 29.12 30.62 -4.90% 26.54 25.37 4.61% 28.28 24.47 15.57% 30.87 25.51 21.01%
Depreciation 24.30 25.10 -3.19% 24.54 25.96 -5.47% 25.34 26.14 -3.06% 25.07 25.83 -2.94%
PBT -4.88 -167.61 - 8.10 -275.33 - 8.02 -15.26 - -12.32 -30.13 -
Tax 0.00 88.79 -100.00% 0.00 0.00 0 0.00 0.00 0 0.00 -10.25 -
PAT -4.88 -256.40 - 8.10 -275.33 - 8.02 -15.26 - -12.32 -19.88 -
PATM -1.79% -85.63% 2.70% -129.91% 2.31% -3.59% -3.39% -5.64%
EPS -1.01 -53.31 - 1.68 -57.24 - 1.67 -3.17 - -2.56 -4.13 -

Description Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var%
Net Sales 273.01 299.43 -8.82% 300.31 211.94 41.70% 346.95 425.24 -18.41% 363.49 352.31 3.17%
Expenses 227.64 289.67 -21.41% 242.63 373.63 -35.06% 285.64 387.61 -26.31% 321.57 333.19 -3.49%
EBITDA 45.37 9.76 364.86% 57.68 -161.69 - 61.31 37.63 62.93% 41.92 19.12 119.25%
EBIDTM 16.62% 3.26% 19.21% -76.29% 17.67% 8.85% 11.53% 5.43%
Other Income 5.95 1.70 250.00% 1.49 0.45 231.11% 0.32 1.18 -72.88% 0.56 2.04 -72.55%
Interest 29.12 30.69 -5.12% 26.54 25.37 4.61% 28.28 24.44 15.71% 30.87 24.61 25.44%
Depreciation 24.30 25.25 -3.76% 24.54 25.96 -5.47% 25.34 26.21 -3.32% 25.07 25.91 -3.24%
PBT -2.10 -166.66 - 8.09 -275.34 - 8.01 -17.06 - -13.46 -29.36 -
Tax 0.00 88.79 -100.00% 0.00 0.00 0 0.00 0.00 0 0.00 -10.25 -
PAT -2.10 -255.45 - 8.09 -275.34 - 8.01 -17.06 - -13.46 -19.11 -
PATM -0.77% -85.31% 2.69% -129.91% 2.31% -4.01% -3.70% -5.42%
EPS -0.52 -65.37 - 2.01 -70.49 - 1.99 -4.39 - -3.35 -5.00 -

Annual Results

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18
Net Sales 1,283.76 1,288.92 1,443.81 1,268.34 1,616.88 1,321.75 1,408.58 560.41 Net Sales Growth -0.40% -10.73% 13.83% -21.56% 22.33% -6.16% 151.35% Cost Of Goods Sold 626.41 805.02 788.83 653.89 724.41 598.87 724.03 293.33 Gross Profit 657.35 483.90 654.98 614.45 892.47 722.88 684.55 267.08 GP Margin 51.21% 37.54% 45.36% 48.45% 55.20% 54.69% 48.60% 47.66% Total Expenditure 1,079.92 1,383.98 1,309.77 1,187.99 1,231.55 1,065.22 1,196.30 499.02 Power & Fuel Cost - 122.56 107.95 93.70 85.42 77.68 79.35 31.41 % Of Sales - 9.51% 7.48% 7.39% 5.28% 5.88% 5.63% 5.60% Employee Cost - 243.92 228.05 234.20 227.63 202.24 185.99 70.54 % Of Sales - 18.92% 15.80% 18.47% 14.08% 15.30% 13.20% 12.59% Manufacturing Exp. - 109.99 91.64 100.57 95.82 94.74 101.85 48.02 % Of Sales - 8.53% 6.35% 7.93% 5.93% 7.17% 7.23% 8.57% General & Admin Exp. - 40.94 39.21 49.55 48.16 50.96 35.72 14.78 % Of Sales - 3.18% 2.72% 3.91% 2.98% 3.86% 2.54% 2.64% Selling & Distn. Exp. - 34.18 32.47 31.83 33.88 26.40 31.33 17.84 % Of Sales - 2.65% 2.25% 2.51% 2.10% 2.00% 2.22% 3.18% Miscellaneous Exp. - 27.37 21.62 24.25 16.23 14.33 38.03 23.10 % Of Sales - 2.12% 1.50% 1.91% 1.00% 1.08% 2.70% 4.12% EBITDA 203.84 -95.06 134.04 80.35 385.33 256.53 212.28 61.39 EBITDA Margin 15.88% -7.38% 9.28% 6.34% 23.83% 19.41% 15.07% 10.95% Other Income 9.14 5.37 22.14 18.76 28.41 27.51 12.03 2.29 Interest 114.81 105.97 90.06 75.27 84.47 77.88 82.48 25.17 Depreciation 99.25 103.03 110.90 112.01 108.31 93.67 83.39 36.56 PBT -1.08 -298.69 -44.78 -88.17 220.96 112.49 58.44 1.95 Tax 0.00 78.54 -22.57 -33.10 0.00 0.00 -0.23 0.00 Tax Rate 0.00% -16.08% 50.40% 36.11% 0.00% 0.00% -0.39% 0.00% PAT -1.08 -566.87 -22.21 -58.56 220.96 112.49 58.67 1.95 PAT before Minority Interest -1.08 -566.87 -22.21 -58.56 220.96 112.49 58.67 1.95 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin -0.08% -43.98% -1.54% -4.62% 13.67% 8.51% 4.17% 0.35% PAT Growth 0.00% - - - 96.43% 91.73% 2,908.72% EPS -0.22 -117.85 -4.62 -12.17 45.94 23.39 12.20 0.41

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18
Net Sales 1,283.76 1,288.92 1,443.81 1,268.35 1,616.88 1,321.75 1,408.58 560.41 Net Sales Growth -0.40% -10.73% 13.83% -21.56% 22.33% -6.16% 151.35% Cost Of Goods Sold 626.41 805.02 788.83 653.89 724.42 598.87 724.03 293.38 Gross Profit 657.35 483.90 654.98 614.46 892.46 722.88 684.55 267.03 GP Margin 51.21% 37.54% 45.36% 48.45% 55.20% 54.69% 48.60% 47.65% Total Expenditure 1,077.48 1,384.10 1,309.93 1,188.38 1,231.01 1,062.31 1,197.03 500.80 Power & Fuel Cost - 122.56 108.10 93.70 85.42 77.68 79.35 31.41 % Of Sales - 9.51% 7.49% 7.39% 5.28% 5.88% 5.63% 5.60% Employee Cost - 243.92 228.63 236.34 229.37 204.13 187.82 71.51 % Of Sales - 18.92% 15.84% 18.63% 14.19% 15.44% 13.33% 12.76% Manufacturing Exp. - 109.98 91.64 100.60 95.82 94.74 101.85 48.02 % Of Sales - 8.53% 6.35% 7.93% 5.93% 7.17% 7.23% 8.57% General & Admin Exp. - 41.07 39.43 49.31 47.86 47.70 35.50 15.22 % Of Sales - 3.19% 2.73% 3.89% 2.96% 3.61% 2.52% 2.72% Selling & Distn. Exp. - 34.18 31.68 30.28 31.88 24.70 31.33 17.84 % Of Sales - 2.65% 2.19% 2.39% 1.97% 1.87% 2.22% 3.18% Miscellaneous Exp. - 27.37 21.62 24.26 16.24 14.49 37.15 23.42 % Of Sales - 2.12% 1.50% 1.91% 1.00% 1.10% 2.64% 4.18% EBITDA 206.28 -95.18 133.88 79.97 385.87 259.44 211.55 59.61 EBITDA Margin 16.07% -7.38% 9.27% 6.31% 23.87% 19.63% 15.02% 10.64% Other Income 8.32 5.37 22.55 20.02 28.77 27.52 12.38 2.47 Interest 114.81 105.11 90.06 75.28 84.48 77.89 82.48 25.17 Depreciation 99.25 103.33 111.19 112.32 108.66 94.16 83.70 36.71 PBT 0.54 -298.25 -44.82 -87.61 221.50 114.91 57.75 0.20 Tax 0.00 78.54 -22.57 -32.81 0.15 0.39 -1.66 -0.14 Tax Rate 0.00% -16.08% 50.36% 36.02% 0.07% 0.34% -2.87% -70.00% PAT 0.54 -567.39 -22.18 -58.15 221.40 114.61 59.51 0.38 PAT before Minority Interest 0.54 -566.96 -22.25 -58.29 221.35 114.52 59.41 0.34 Minority Interest 0.00 -0.43 0.07 0.14 0.05 0.09 0.10 0.04 PAT Margin 0.04% -44.02% -1.54% -4.58% 13.69% 8.67% 4.22% 0.07% PAT Growth 100.10% - - - 93.18% 92.59% 15,560.53% EPS 0.11 -117.96 -4.61 -12.09 46.03 23.83 12.37 0.08

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18
Shareholder's Funds 937.42 1,503.13 1,527.05 1,592.79 1,090.79 962.45 769.87 Share Capital 36.00 36.00 36.00 35.93 26.85 25.77 24.67 Total Reserves 899.77 1,466.08 1,490.05 1,553.07 963.21 830.29 745.19 Non-Current Liabilities 171.53 217.16 299.22 206.53 333.09 344.00 314.88 Secured Loans 105.83 235.10 283.04 154.83 232.71 224.97 242.86 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 53.67 49.03 37.07 36.56 32.62 28.79 23.58 Current Liabilities 1,237.65 1,096.12 1,056.03 785.30 727.73 650.33 732.42 Trade Payables 307.70 300.69 268.54 305.62 215.72 242.52 312.59 Other Current Liabilities 167.71 144.55 174.15 116.97 156.36 190.99 88.35 Short Term Borrowings 760.27 648.80 609.90 360.88 353.79 214.46 330.21 Short Term Provisions 1.97 2.08 3.44 1.83 1.86 2.36 1.27 Total Liabilities 2,346.60 2,816.41 2,882.30 2,584.62 2,151.61 1,956.78 1,817.17 Net Block 1,258.70 1,333.22 1,325.00 1,359.01 1,374.09 1,194.74 1,062.54 Gross Block 1,869.35 1,860.64 1,753.44 1,678.31 1,587.46 1,315.86 1,099.10 Accumulated Depreciation 610.65 527.42 428.44 319.30 213.37 121.12 36.56 Non Current Assets 1,555.95 1,625.54 1,642.43 1,526.63 1,476.26 1,307.12 1,208.63 Capital Work in Progress 256.37 238.47 238.65 87.72 40.21 39.20 70.31 Non Current Investment 14.25 16.05 14.77 18.13 18.03 18.12 18.53 Long Term Loans & Adv. 23.76 28.50 54.38 60.60 39.55 35.63 48.23 Other Non Current Assets 0.48 0.51 0.48 1.17 4.38 19.43 9.03 Current Assets 790.65 1,190.87 1,239.87 1,057.99 675.35 649.66 608.53 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 359.70 558.09 575.55 294.97 279.73 213.94 187.66 Sundry Debtors 351.22 539.65 489.67 483.81 229.67 290.24 263.35 Cash & Bank 8.48 8.71 47.14 198.38 56.58 76.37 46.93 Other Current Assets 71.25 24.08 18.67 73.51 109.37 69.11 110.59 Short Term Loans & Adv. 52.41 60.34 108.84 7.32 19.07 19.59 35.10 Net Current Assets -447.00 94.75 183.84 272.69 -52.38 -0.67 -123.89 Total Assets 2,346.60 2,816.41 2,882.30 2,584.62 2,151.61 1,956.78 1,817.16

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18
Shareholder's Funds 933.91 1,500.21 1,524.87 1,588.53 1,085.94 955.87 763.98 Share Capital 36.00 36.00 36.00 35.93 26.85 25.77 24.67 Total Reserves 896.26 1,463.16 1,487.87 1,548.81 958.36 823.71 739.30 Non-Current Liabilities 171.53 217.14 299.22 206.46 333.31 344.23 315.06 Secured Loans 105.83 235.10 283.04 154.83 232.71 224.97 242.86 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 53.67 49.03 37.07 36.56 32.62 28.79 23.58 Current Liabilities 1,242.79 1,101.13 1,063.42 788.74 729.89 655.50 737.95 Trade Payables 313.01 305.86 275.99 309.29 216.12 244.38 312.87 Other Current Liabilities 167.53 144.38 173.76 116.60 157.28 192.24 90.08 Short Term Borrowings 760.27 648.80 609.90 360.88 353.79 214.47 330.21 Short Term Provisions 1.98 2.09 3.77 1.97 2.70 4.41 4.78 Total Liabilities 2,350.90 2,820.72 2,889.82 2,587.97 2,153.43 1,959.98 1,821.47 Net Block 1,265.50 1,340.02 1,331.80 1,381.58 1,396.94 1,217.80 1,085.93 Gross Block 1,876.36 1,867.65 1,760.45 1,702.15 1,611.23 1,339.37 1,122.64 Accumulated Depreciation 610.86 527.63 428.65 320.57 214.29 121.57 36.71 Non Current Assets 1,550.21 1,633.18 1,650.54 1,530.34 1,481.44 1,311.88 1,213.66 Capital Work in Progress 256.37 238.47 238.65 87.98 40.47 40.37 71.48 Non Current Investment 1.70 1.70 0.42 0.42 0.32 0.41 0.81 Long Term Loans & Adv. 23.77 28.54 54.60 59.19 40.83 36.23 46.40 Other Non Current Assets 0.48 0.51 0.48 1.17 2.88 17.07 9.03 Current Assets 788.07 1,187.54 1,239.28 1,057.63 671.99 648.10 607.81 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 359.70 558.09 575.55 294.97 279.73 213.94 187.66 Sundry Debtors 348.52 536.99 489.67 483.87 226.53 288.80 262.52 Cash & Bank 8.60 8.89 47.25 198.54 56.78 76.47 47.01 Other Current Assets 71.25 23.22 17.94 72.93 108.95 68.89 110.62 Short Term Loans & Adv. 52.41 60.35 108.87 7.32 69.08 19.76 35.14 Net Current Assets -454.72 86.41 175.86 268.89 -57.90 -7.40 -130.14 Total Assets 2,338.28 2,820.72 2,889.82 2,587.97 2,153.43 1,959.98 1,821.47

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18
Cash From Operating Activity 110.95 156.17 -241.77 154.44 242.02 165.72 49.63 PBT -488.33 -44.78 -91.66 220.96 112.49 58.44 1.95 Adjustment 405.79 186.88 181.98 173.16 167.54 148.31 62.33 Changes in Working Capital 192.57 0.36 -314.04 -207.11 -14.50 -26.51 -11.67 Cash after chg. in Working capital 110.03 142.46 -223.72 187.01 265.53 180.24 52.61 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid 0.92 13.71 -18.05 -32.57 -23.51 -14.52 -2.98 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -4.66 -81.13 -243.08 -105.25 -358.81 -115.64 -85.49 Net Fixed Assets -26.61 -107.02 -226.06 -138.36 -272.61 -185.65 Net Investments 1.80 -1.28 3.36 -0.10 0.09 0.41 Others 20.15 27.17 -20.38 33.21 -86.29 69.60 Cash from Financing Activity -106.52 -112.76 333.59 92.50 97.01 -23.00 67.36 Net Cash Inflow / Outflow -0.23 -37.72 -151.26 141.69 -19.78 27.08 31.50 Opening Cash & Equivalents 8.55 46.27 197.53 55.84 75.62 45.87 0.00 Closing Cash & Equivalent 8.32 8.55 46.27 197.53 55.84 75.62 45.87

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18
Cash From Operating Activity 108.87 156.25 -242.03 155.46 242.15 166.33 49.22 PBT -488.42 -44.82 -91.10 221.50 114.91 57.75 0.20 Adjustment 405.76 186.79 180.96 173.16 168.03 148.26 62.76 Changes in Working Capital 190.63 0.74 -313.79 -205.84 -16.45 -25.29 -10.84 Cash after chg. in Working capital 107.97 142.71 -223.93 188.82 266.49 180.72 52.11 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid 0.90 13.54 -18.10 -33.36 -24.34 -14.39 -2.89 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -3.51 -81.14 -242.85 -106.30 -358.81 -115.69 -85.47 Net Fixed Assets -26.61 -107.02 -226.06 -138.36 -272.61 -185.65 Net Investments 1.80 -1.28 3.36 -0.10 0.09 0.41 Others 21.30 27.16 -20.15 32.16 -86.29 69.55 Cash from Financing Activity -105.65 -112.76 333.57 92.49 96.98 -23.39 67.74 Net Cash Inflow / Outflow -0.29 -37.65 -151.31 141.65 -19.68 27.25 31.49 Opening Cash & Equivalents 8.73 46.38 197.69 56.04 75.72 45.95 0.00 Closing Cash & Equivalent 8.44 8.73 46.38 197.69 56.04 75.72 45.95

Financial Ratios

Standalone /

Consolidated

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18
Book Value (Rs.) 239.57 384.55 423.90 442.25 368.74 332.19 312.02 ROA -21.96% -0.78% -2.14% 9.33% 5.48% 3.11% 0.11% ROE -46.51% -1.47% -3.76% 17.13% 12.19% 7.22% 0.25% ROCE -17.22% 1.79% -0.69% 15.28% 11.54% 9.71% 1.93% Fixed Asset Turnover 0.69 0.80 0.74 0.99 0.91 1.17 0.51 Receivable days 126.14 130.11 140.07 80.53 71.79 71.72 171.52 Inventory Days 129.95 143.29 125.26 64.87 68.16 52.03 122.23 Payable days 137.92 131.69 160.25 131.34 75.41 84.29 228.78 Cash Conversion Cycle 118.17 141.71 105.08 14.06 64.54 39.47 64.97 Total Debt/Equity 1.07 0.67 0.67 0.38 0.71 0.63 0.82 Interest Cover -3.61 0.50 -0.22 3.62 2.44 1.71 1.08

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18
Book Value (Rs.) 238.67 383.80 423.30 441.06 366.93 329.64 309.63 ROA -21.93% -0.78% -2.13% 9.34% 5.57% 3.14% 0.02% ROE -46.64% -1.47% -3.75% 17.23% 12.48% 7.36% 0.04% ROCE -17.29% 1.79% -0.67% 15.34% 11.73% 9.70% 1.82% Fixed Asset Turnover 0.69 0.80 0.73 0.98 0.90 1.14 0.50 Receivable days 125.38 129.77 140.08 80.18 71.15 71.43 170.98 Inventory Days 129.95 143.29 125.26 64.87 68.16 52.03 122.23 Payable days 140.30 134.61 163.35 132.36 75.74 84.47 228.45 Cash Conversion Cycle 115.03 138.45 101.99 12.69 63.58 39.00 64.76 Total Debt/Equity 1.07 0.67 0.67 0.38 0.72 0.63 0.83 Interest Cover -3.65 0.50 -0.21 3.62 2.48 1.70 1.01

Top Investors:

spiracca ventures llp .

authum investment and infrastructure limited

tpg growth iv sf pte. ltd.

the scottish oriental smaller companies trustplc

hbm healthcare investments (cayman) ltd

fssa indian subcontinent fund as sub fund of first sentier investors global umbrella fundplc

caisse de depot et placement du quebec - first sentier investors international im limited

route one offshore master fund, l.p.

raptakos brett & co limited

Annual Reports:

News Update:

USFDA concludes inspection at Solara’s Ambernath facility
10th May 2025, 16:54 PM

The inspection established that the site is in an ‘Acceptable State of Compliance’ with Zero Form 483 inspectional observations from USFDA
Read More
Solara Active Pharma Sciences incorporates wholly-owned subsidiary
30th Apr 2025, 09:19 AM

The company has incorporated wholly-owned subsidiary on April 29, 2025
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback